BusinessLawsuit for Investors in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) over alleged Violations of Securities Laws announced by Shareholders FoundationBy Nasdaq OMXNov 29, 2016, 6:35 PM UTC